Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.

Literature DB >> 2999572

Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.

P J Holmes, J A Hallworth, D I Stocker, G R Skinner.

Abstract

Optimal neutralisation of type 1 herpes simplex virus was obtained by reacting undiluted human serum with virus for 4 h at 37 degrees C, followed by addition of antihuman globulin for 20 min; under these conditions it was possible to detect neutralising antibody activity in 40 of 45 human sera (88%) previously adjudged to be negative by conventional neutralisation tests.

Entities: Species

Mesh：

Substances：

Year: 1985 PMID： 2999572 DOI： 10.1007/bf02123693

Source DB: PubMed Journal: Med Microbiol Immunol ISSN： 0300-8584 Impact factor: 3.402

20 in total

1. THE APPEARANCE OF COMPLEMENT-REQUIRING NEUTRALIZING ANTIBODIES BY IMMUNIZATION AND INFECTION WITH HERPES SIMPLEX VIRUS.

Authors: K YOSHINO; S TANIGUCHI
Journal: Virology Date: 1964-02 Impact factor: 3.616

2. STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. 3. MECHANISM OF THE ANTIBODY-POTENTIATING ACTION OF COMPLEMENT.

Authors: K YOSHINO; S TANIGUCHI
Journal: Virology Date: 1965-05 Impact factor: 3.616

3. A sensitive and precise plaque assay for herpes virus.

Authors: W C RUSSELL
Journal: Nature Date: 1962-09-08 Impact factor: 49.962

4. Serological relatedness of herpes simplex viruses. Type-specificity of antibody response.

Authors: G R Skinner; M E Thouless; S Trueman; J Edwards; A J Gibbs
Journal: Immunology Date: 1976-09 Impact factor: 7.397

5. Measurement of antibody against human IgG by the neutralization of IgG-sensitized herpes simplex virus.

Authors: C A Daniels; S E Mergenhagen; A L Notkins
Journal: J Immunol Date: 1970-02 Impact factor: 5.422

6. Virus specific antigens in mammalian cells infected with herpes simplex virus.

Authors: D H Watson; W I Shedden; A Elliot; T Tetsuka; P Wildy; D Bourgaux-Ramoisy; E Gold
Journal: Immunology Date: 1966-10 Impact factor: 7.397

7. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ.

Authors: E Adam; R H Kaufman; J L Melnick; A H Levy; W E Rawls
Journal: Am J Epidemiol Date: 1973-08 Impact factor: 4.897

8. The association of herpesvirus type 2 and carcinoma of the uterine cervix.

Authors: W E Rawls; W A Tompkins; J L Melnick
Journal: Am J Epidemiol Date: 1969-05 Impact factor: 4.897

9. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.

Authors: G R Skinner; C B Woodman; C E Hartley; A Buchan; A Fuller; J Durham; M Synnott; J C Clay; J Melling; C Wiblin; J Wilkins
Journal: Br J Vener Dis Date: 1982-12

10. Neutralization of residual infectivity of Venezuelan equine encephalomyelitis virus by anti-gamma globulin.

Authors: N Hahon
Journal: J Gen Virol Date: 1970-03 Impact factor: 3.891

4 in total

1. Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis.

Authors: G R Skinner; C Fink; J Melling; C Wiblin; B Thornton; J Hallworth; W Gardner; P McLeish; C Hartley; A Buchan
Journal: Med Microbiol Immunol Date: 1992 Impact factor: 3.402